Idan kuna bincike kan kwayoyin levothyroxine da masu cin zuma don magance hypothyroidism, zaku ji game da bincike kan Hukumar Abinci da Harkokin Kiyaye ta Amurka (FDA) a cikin Mylan. Mylan shi ne mafi girma na uku na mafi girma a duniya, kuma maƙerin kwayar cutar levothyroxine da liothyronine, jigon kwayoyin cutar Cytomel . Dukansu kwayoyi ne thyroid hormone sauyawa magunguna amfani da su warware hypothyroidism.
A lokacin rani na 2009, FDA ta bude wani bincike, amma a cikin makonnin da yawa, an gudanar da bincike, kuma babu wani shaida da cewa an yi amfani da kwayoyi na Mylan, ciki har da levothyroxine.
Anan ne bayanin da kuke buƙatar sanin don yin bayani game da waɗannan magunguna.
Bayanan
A shekara ta 2009, Mylan ya zama tushen batun bincike na tarayya game da matsalolin da suke samarwa a cikin shuka. Labarin Pittsburgh Post Gazette ya ba da labari game da ma'aikata a cikin kamfanin Mylan na West Virginia, wadanda suka kasance, bisa ga takardun ciki da aka samu ta Post-Gazette , "sunyi tawaye da kwarewa game da matsalolin matsaloli da magungunan da suke samarwa."
A wannan lokacin, FDA ta yi zargin cewa Mylan ya shiga cikin lalata bayanai da canza kayan aiki, watakila na tsawon shekaru biyu ko fiye. Bayan da FDA ta bude wani binciken a cikin Mylan, kamfanin ya ba da wata sanarwa da ya nuna cewa bincike na FDA ya kasance na yau da kullum.
FDA, duk da haka, ya dauki mataki mai ban mamaki na bayar da wata sanarwa don magance matsalar da aka yi a kokarin da Mylan ya yi don rage girman bincike.
A lokacin da aka kaddamar da binciken, Pittsburgh Post-Gazette ya ba da cikakkun bayanai game da halin Mylan, ciki har da waɗannan abubuwa masu zuwa:
- Ma'aikata na Mylan sun shafe magungunan ingancin miyagun ƙwayoyi, Bayanin gida na cikakkiyar aikin 'ƙwaƙwalwa' na rashin watsi da hanyoyin kiyaye lafiya - Yuli 26, 2009
- Mylan ta 'red allon' lokaci - Yuli 26, 2009
- FDA ta binciko abubuwan da Mylan ke yi, An gabatar da hakikanin ketare a cikin rahoton na ciki - Yuli 28, 2009
- "FDA ta gurfanar da sanarwa na Mylan" - Yuli 28, 2009
Bayan makonni da dama a lokacin da farashin farashin Mylan ya ɓata, kuma Mylan da FDA sun gudanar da yakin basasa a cikin jarida. Mylan kuma ya yi wa manema labarun Pittsburgh Post Gazette labarin cewa ya karya labarun don cin zarafi.
FDA ta ƙare tsararre Mylan, ta sanar da ranar 13 ga Agusta, 2009. A cewar FDA, Mylan ya gudanar da bincike mai kyau, wakilin kamfanin dillancin labaran, kuma FDA ta rufe binciken.
An yanke hukunci game da Jaridar Mylan a shekarar 2012, kuma Mylan da Post-Gazette sun bayar da wata sanarwa da ta ce, a wani ɓangare:
An yanke hukuncin ne don samun gamsar da bangarorin biyu. Bayanan Post-Gazette bai samu ba kuma baiyi nufin bayar da rahoto cewa Mylan ya kayyade ko rarraba wasu kwayoyi mara kyau ba.
Kalma daga
Halin wannan halin da ake ciki ga marasa lafiyarka shine cewa babu wata shaida da cewa ingancin maganin da Mylan ya gina, ciki har da magungunan levothyroxine da kuma honeythyronine da mutane da dama suka dauka tare da hypothyroidism, sun shafi kowace hanya.
A lokaci guda, mutane da hypothyroidism ɗauke da thyroid hormone sauyawa miyagun ƙwayoyi levothyroxine bukatar mu sani cewa da yawa likitoci ba BA bayar da shawarar cewa thyroid marasa lafiya dauki wani generic levothyroxine daga wani manufacturer. Dalilin shi ne cewa dukkanin kwayoyi na levothyroxine, ciki har da kwayoyi masu mahimmanci da sunaye, an halatta su yarda da su su bambanta da matakan daga 95 zuwa 105 bisa dari na maganin. Yayin da za a dauki levothyroxine, za a iya kwashe su daga kowane mai sana'a, wanda ke nufin cewa kowannensu ya cika mahimmin sashi zai iya fada a ko'ina a cikin wannan tasirin.
Koda mawuyacin bambancin aiki zai iya tsoma baki tare da tasiri na maye gurbin thyroid hormone.
Stable thyroid hormone sauyawa ma musamman da muhimmanci ga thyroid ciwon daji tsira, wanda zai iya buƙatar consistently suppressed thyroid stimulating hormone (TSH) matakan a matsayin wani ɓangare na jiyya, da kuma hana sake komawa da thyroid ciwon daji.
Idan kana shan kwayar levothyroxine daga kowane mai sana'a, yana da amfani don tattauna halinka na musamman tare da mai kula da lafiyarka, don sanin idan magungunan miyagun ƙwayoyi zai zama mafi kyau don zaɓarka.